| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |